Advances in Clinical Chemistry

1st Edition - April 4, 2014

Editor: Gregory S. Makowski

Hardback ISBN:

9 7 8 - 0 - 1 2 - 8 0 0 2 6 3 - 6

eBook ISBN:

9 7 8 - 0 - 1 2 - 8 0 0 3 0 4 - 6

Volume 64 in the internationally acclaimed Advances in Clinical Chemistry contains chapters authored by world renowned clinical laboratory scientists, physicians and research… Read more

Purchase Options

LIMITED OFFER

Save 50% on book bundles

Immediately download your ebook while waiting for your print delivery. No promo code is needed.

Volume 64 in the internationally acclaimed Advances in Clinical Chemistry contains chapters authored by world renowned clinical laboratory scientists, physicians and research scientists. The serial provides the latest and most up-to-date technologies related to the field of Clinical Chemistry and is the benchmark for novel analytical approaches in the clinical laboratory.

Preface
Chapter One: Matrix Metalloproteinases in Coronary Artery Disease
- Abstract
- Acknowledgments
- 1 Introduction
- 2 Classification, Structure, and Function of MMP
- 3 Regulation of MMP
- 4 MMP in Cardiovascular System Development
- 5 MMP in Coronary Artery Disease
- 6 Genetics of Matrix Metalloproteinases
- 7 Matrix Metalloproteinases and Therapeutic Aspects
- 8 Prognostic Value of ECM Biomarkers
- 9 Conclusion
Chapter Two: Heat Shock Proteins and Cardiovascular Disease
- Abstract
- 1 Introduction
- 2 Atherogenesis and HSP
- 3 Therapeutic Implications
- 4 HSPs as Predictors of CVD
- 5 Immunization and Vaccination with HSP
- 6 Effects of Therapeutic Interventions on HSP
- 7 Conclusion
Chapter Three: Apolipoprotein B-48: A Unique Marker of Chylomicron Metabolism
- Abstract
- Acknowledgment
- 1 Introduction
- 2 Discovery of apoB48
- 3 ApoB48 and mRNA Editing; Stop Codon and Translational Termination of Intestinal apoB mRNA
- 4 ApoB-48, MTP, and apoA-IV in CM Formation
- 5 Metabolism of apoB-48 Containing CM, apoB-100 Containing VLDL, and Their Remnants in Plasma
- 6 Biochemistry of CM and VLDL Remnants
- 7 ApoB-48 Receptor
- 8 Kinetics of apoB-48 Containing Lipoproteins
- 9 Daily Rhythm of Plasma TG, apoB-48, and Remnant Lipoproteins and Their Changes After Fat Load
- 10 Analytical Approach to apoB48
- 11 Plasma apoB48 Containing Particles as a Risk Marker for Cardiovascular Diseases
- 12 Familial Chylomicronemia
- 13 Prevention of Cardiovascular Disease
- 14 Treatment of Cardiovascular Disease; Statins, Fibrates, EPA, LPL Gene Therapy
- 15 Summary
Chapter Four: Neutrophil Gelatinase-Associated Lipocalin in Cancer
- Abstract
- 1 Structure and Biology of Human Neutrophil Gelatinase-Associated Lipocalin
- 2 Review of Epidemiological Evidence
- 3 Review of Biological Evidence
- 4 Conclusions
Chapter Five: Autoantibodies in Breast Cancer
- Abstract
- 1 Introduction
- 2 Improved Screening Mammography with an Antibody-Based Classifier
- 3 Value of an Accurate Autoantibody-Based Breast Cancer (BC) Screening Test
- 4 BC-Associated Autoantibodies and Diagnostic Panels
- 5 Validation of Diagnostic Antibody-Based Classifiers
- 6 Autoantibodies in Premalignancy
- 7 Breast Cancer Autoantibodies: Biological Significance or Epiphenomena?
- 8 Conclusion
Chapter Six: Mammaglobin A: Review and Clinical Utility
- Abstract
- Acknowledgments
- 1 Mammaglobin A: Gene and Protein Structure
- 2 Expression of Mamaglobin A in Healthy Tissue and Primary Tumors
- 3 Cancer and Metastasis
- 4 Breast Cancer
- 5 Dissemination Sites and Material Source for Cancer Cell Detection
- 6 Methods for CTC Analysis
- 7 Clinical Relevance of CTC Detection
- 8 Markers Used for Molecular Detection of CTC
- 9 Mammaglobin A and Breast Cancer
- 10 Detection of Micrometastasis
- 11 Mammaglobin A Detection: Clinical Value
- 12 Mammaglobin A as a Target for Cancer Therapy
- 13 Conclusion
Chapter Seven: 1,5-Anhydroglucitol and Glycated Albumin in Glycemia
- Abstract
- 1 Introduction
- 2 Glycated Hemoglobin (HbA1c)
- 3 1,5-Anhydroglucitol
- 4 Fructosamine and Glycated Albumin
- 5 Usefulness and Problems of Various Indices in Various Clinical States
- 6 Conclusions
Index